Review of therapies to increase the response of melanocytic activity to skin repigmentation of patients with vitiligo
DOI:
https://doi.org/10.33448/rsd-v10i11.19460Keywords:
Repigmentation; Vitiligo; Phototherapy; Mama-cadela; Corticosteroids.Abstract
Vitiligo is an immunological disease characterized by depigmentation of the skin, causing achromic spots, with no predilection for sex or ethnicity. Furthermore, it can cause emotional changes, compromise the individual's self-esteem and social relationships. Thus, this work proposes a systematic review of the literature aiming to evidence the efficiency of available therapy protocols for vitiligo and their correlation. Methodology: This is a systematic review study, descriptive and retrospective, carried out based on research in the main academic databases. Ex. PubMed, Lilacs and Capes Periodics, etc. Thus, free searches were made for words related to the proposed theme: vitiligo treatment and this associations, excluding studies that showed inefficiency (low percentage of repigmentation) when compared to conventional treatments. In this sense, 35 scientific articles and 27 different therapies for the treatment of vitiligo were found. Results and Discussion: Such therapies were divided into 4 categories: corticosteroids, photobiomodulation, immunosuppressants and antioxidants. The use of corticosteroids proved to be effective in stabilizing the disease. Phototherapies added kelina acted in 70% of the cases of repigmentation. JAK immunosuppressants demonstrated a total of repigmentation above 75%. And the antioxidants showed 67% efficacy of repigmentation, with emphasis on the species Polypodium leucotomos and Brosimum gaudichaudii with a high index of complete repigmentation, especially when associated with UVB radiation. Treatment with Ginko biloba had 80% disease stabilization. Conclusion: The protocols showed that the association of phototherapies with conventional and innovative therapies are more often effective in the treatment of vitiligo, enhancing the results.
References
Abdel-Fattah, A., Aboul-Enein, M. N., Wasset, G. M., & El-Menshawi, B. S. (1982). Uma abordagem para o tratamento do vitiligo por khellin. Dermatology, 165 (2), 136-140.
Akyol, M., Celik, V. K., Ozcelik, S., Polat, M., Marufihah, M., & Atalay, A. (2002). The effects of vitamin E on the skin lipid peroxidation and the clinical improvement in vitiligo patients treated with PUVA. EJD, 12(1), 24-26.
Arany, P. R. et al. (2014) Photoactivation of Endogenous Latent Transforming Growth Factor. Directs Dental Stem Cell Differentiation for Regeneration. Science Translational Medicine, 6 (238), 238ra69-238ra69.
Barona, M. I., et al. (1995) An epidemiologic case-control study in a population with vitiligo. Journal of the American Academy of Dermatology, 33 (4), 621–625.
Birlea, S. A., et al. (2017) Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization. Medicinal Research Reviews, 37 (4), 907–935.
Craiglow, B. G., & King, B. A. (2014). Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis. The Journal of investigative dermatology, 134(12), 2988.
Craiglow, B. G., & King, B. A. (2015). Tofacitinib citrate for the treatment of vitiligo: a pathogenesis-directed therapy. JAMA dermatology, 151(10), 1110-1112.
Cunha, P. R., Scabine Pessotti, N., Bonati Mattos, C., & Salai, A. F. (2017). New approach in the treatment of refractory vitiligo: CO2 laser combined with betamethasone and salicylic acid solution. Dermatologic therapy, 30(1), e12410.
Cupertino, F., Niemeyer-Corbellini, J. P., & Ramos-e-Silva, M. (2017). Psychosomatic aspects of vitiligo. Clinics in dermatology, 35(3), 292-297.
De Freitas, L. F., & Hamblin, M. R. (2016) Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy. IEEE Journal of Selected Topics in Quantum Electronics, 22 (3), 348–364.
Doppalapudi, S., Jain, A., Chopra, D. K., & Khan, W. (2017). Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis. European journal of pharmaceutical sciences, 96, 515-529.
Dos Santos, L. G. D. J., Coutinho, A. M., Damasceno, E. M. A., & Soares, N. Z. D. (2019). Determinação dos fenóis totais e da atividade antioxidante da Brosimum gaudichaudii. Brazilian Journal of Health and Pharmacy, 1(3), 28-33.
Emanuel, P., & Scheinfeld, N. (2007). Uma revisão do reparo de DNA e possíveis adjuvantes de reparo de DNA e antioxidantes naturais selecionados. Jornal online de dermatologia, 13 (3).
Estrela, C. (2018). Metodologia científica: ciência, ensino, pesquisa. Artes Médicas.
Ezzedine, K., Sheth, V., Rodrigues, M., Eleftheriadou, V., Harris, J. E., Hamzavi, I. H., & Pandya, A. G. (2015). Vitiligo is not a cosmetic disease. Journal of the American Academy of Dermatology, 73(5), 883-885.
Faria, R. A. P. G., et al. (2015) Fenologia de Brosimum gaudichaudii trÉcul. (Moraceae) no cerrado de mato grosso. Ciencia Florestal, 25 (1), 67–75.
Fushimi, T., et al. (2012) Green light emitting diodes accelerate wound healing: Characterization of the effect and its molecular basis in vitro and in vivo. Wound Repair and Regeneration, 20 (2), 226–235.
Gonçalves, J. A. B. (2019). Avaliação dos protocolos para abordagem de vitiligo: Síntese de evidências. UNILUS Ensino e Pesquisa, 16(42), 97-111.
Hamblin, M. R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 4 (3), 337–361.
Hofer, A., Kerl, H., & Wolf, P. (2001). Long-term results in the treatment of vitiligo with oral khellin plus UVA. European Journal of Dermatology, 11(3), 225-9.
Kanwar, A. J., Mahajan, R., & Parsad, D. (2013). Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo. Journal of cutaneous medicine and surgery, 17(4), 259-268.
Karu, T. I. (1986). Molecular mechanism of the therapeutic effect of low-intensity laser irradiation. Doklady Akademii nauk SSSR, 291 (5), 1245–9.
Khan, I., & Arany, P. R (2016). Photobiomodulation Therapy Promotes Expansion of Epithelial Colony Forming Units. Photomedicine and Laser Surgery, 34 (11), 550–555.
Kim, S. R., Heaton, H., Liu, L. Y., & King, B. A. (2018). Rapid repigmentation of vitiligo using tofacitinib plus low-dose, narrowband UV-B phototherapy. JAMA dermatology, 154(3), 370-371.
Koh, M. J. A., Mok, Z. R., & Chong, W. S. (2015). Fototerapia para o tratamento do vitiligo em crianças asiáticas. Dermatologia pediátrica, 32 (2), 192-197.
Kwok, Y. K. C., Anstey, A. V., & Hawk, J. L. M. (2002). Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo: a 10‐year retrospective study. Clinical and experimental dermatology, 27(2), 104-110.
Land, L. R. B., Borges, F. M., Borges, D. O., & Pascoal, G. B. (2017). Composição centesimal, compostos bioativos e parâmetros físico-químicos da mama-cadela (Brosimum gaudichaudii Tréc) proveniente do Cerrado Mineiro. Demetra: alimentação, nutrição & saúde, 12(2), 509-518.
Lee, J. T., & Herlyn, M. (2012). MEK'ing o máximo da terapia de reativação de p53 no melanoma. Journal of Investigative Dermatology, 132 (2), 263-265.
Leone, G., Pacifico, A., Iacovelli, P., Vidolin, A. P., & Picardo, M. (2006). Tacalcitol and narrow‐band phototherapy in patients with vitiligo. Clinical and Experimental Dermatology: Clinical dermatology, 31(2), 200-205.
Lerner, A. B., Denton, C. R., & Fitzpatrick, T. B. (1953). Clinical and experimental studies with 8-methoxypsoralen in vitiligo. Journal of Investigative Dermatology, 20(4), 299-314.
Lima, M. R., Santos, P. D. A., Silveira, C. E. S., Palhares, D., & Pereira, L. A. R. (2014). Cultivo in vitro de Brosimum gaudichaudii Tréc. (Moraceae). Revista Brasileira de Plantas Medicinais, 16, 462-466.
Macedo, A. C. B. D., Oliveira, C. F. D., Silva, E. C. M., & Andrade, L. A. S. D. (2012). Efeitos da aplicação do LASER HeNe e do ultravioleta B no vitiligo. Fisioterapia em Movimento, 25, 481-488.
Middelkamp‐Hup, M. A., Bos, J. D., Rius‐Diaz, F., Gonzalez, S., & Westerhof, W. (2007). Treatment of vitiligo vulgaris with narrow‐band UVB and oral Polypodium leucotomos extract: a randomized double‐blind placebo‐controlled study. Journal of the European Academy of Dermatology and Venereology, 21(7), 942-950.
Mohammad, A. (1989). Vitiligo repigmentation with Anapsos (Polypodium leucotomos). International journal of dermatology, 28(7), 479-479.
Moser, C. D. S., et al. (2019) Caracterização de compostos bioativos e atividade antioxidante de amora-preta produzidas no oeste de Santa Catarina. In: A Face Multidisciplinar das Ciências Agrárias 4. [s.l.] Atena Editora.
Nunes, D. H., & Esser, L. M. H. (2011) Perfil epidemiológico dos pacientes com vitiligo e sua associação com doenças da tireoide. Anais Brasileiros de Dermatologia, 86 (2), 241–248.
Ongenae, K., Van Geel, N., & Naeyaert, J. M. (2003) Evidence for an Autoimmune Pathogenesis of Vitiligo. Pigment Cell Research, 16 (2), 90–100.
Ortel, B., Tanew, A., & Hönigsmann, H. (1988). Treatment of vitiligo with khellin and ultraviolet A. Journal of the American Academy of Dermatology, 18(4), 693-701.
Parsad, D., Dogra, S., & Kanwar, A. J. (2003). Quality of life in patients with vitiligo. Health and quality of life outcomes, 1(1), 1-3.
Pathak, P. C., Pandey, A. N., & Singh, J. S. (1984). Overland flow, sediment output and nutrient loss from certain forested sites in the central Himalaya, India. Journal of Hydrology, 71(3-4), 239-251.
Patra, S., Khaitan, B. K., Sharma, V. K., & Khanna, N. (2019). A randomized comparative study of the effect of betamethasone oral mini-pulse therapy versus oral azathioprine in progressive non-segmental vitiligo. Journal of the American Academy of Dermatology.
Pinto, M., Bani, G., & Paiva, P. (2015). Mecanismo de indução de tolerância oral no tratamento de doenças autoimunes. Revista da UI_IP Santarém-Unidade de Investigação do Instituto Politécnico de Santarém.
Ports, W. C., Khan, S., Lan, S., Lamba, M., Bolduc, C., Bissonnette, R., & Papp, K. (2013). Um ensaio randomizado de fase 2a de eficácia e segurança do inibidor tópico da J anus quinase tofacitinibe no tratamento da psoríase crônica em placas. British Journal of Dermatology , 169 (1), 137-145.
Pozetti, G. L. (2005). Brosimum gaudichaudii Trecul (Moraceae): da planta ao medicamento. Revista de Ciências Farmacêuticas Básica e Aplicada, 26(3).
Rashighi, M., & Harris, J. E. (2015) Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo. Annals of Translational Medicine, 3 (21), 1–5.
Reyes, E., Jaén, P., de las Heras, E., de Eusebio, E., Carrión, F., Cuevas, J., & Álvarez-Mon, M. (2006). Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: A pilot study. Journal of dermatological science, 41(3), 213-216.
Rosmarin, D. et al. (2020). Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial. The Lancet, 396 (10244), 110–120.
Singh, A., Kanwar, A., Parsad, D., & Mahajan, R. (2014). Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris. Indian Journal of Dermatology, Venereology and Leprology, 80(1), 29.
Singh, H., Kumaran, M. S., Bains, A., & Parsad, D. (2015). A randomized comparative study of oral corticosteroid minipulse and low-dose oral methotrexate in the treatment of unstable vitiligo. Dermatology, 231(3), 286-290.
Souza, L. K. (2017) Abordagem sobre causas, qualidade de vida e tratamento de portadores de psoríase e vitiligo. [s.l.] Universidade Feevale.
Strassner, J. P. et al. (2017) Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity. Journal of the American Academy of Dermatology, 76 (5), 847- 855.
Szczurko, O., & Boon, H. S. (2008). A systematic review of natural health product treatment for vitiligo. BMC dermatology, 8(1), 1-12.
Szczurko, O., Shear, N., Taddio, A., & Boon, H. (2011). Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial. BMC complementary and alternative medicine, 11(1), 1-9.
Tovar-Garza, A., Hinojosa, J. A., Hynan, L. S., & Pandya, A. G. (2018). Addition of oral minipulse dexamethasone to narrowband ultraviolet B phototherapy and topical steroids helps arrest disease activity in patients with vitiligo. The British journal of dermatology, 180(1), 193-194.
Vussuki, E., Ziv, M., Rosenman, D., & David, M. (2006). Long-term effects of PUVA therapy on Israeli patients with vitiligo. Harefuah, 145(7), 483-5.
Whitton, M. E., Pinart, M., Batchelor, J., Leonardi-Bee, J., González, U., Jiyad, Z., Eleftheriadou, V., & Ezzedine, K. (2015). Interventions for vitiligo. The Cochrane database of systematic reviews, (2).
Zhou, X., Zhang, G., & Wang, L. (2014) Probing the binding mode of psoralen to calf thymus DNA. International Journal of Biological Macromolecules, 67, 228–237.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Karla Mileny Monteiro Ventura; Jonathan Potiguara de Miranda; Elaine Queiroz da Costa; Diego da Silva Santana; Juan Gonzalo Bardález Rivera; Russany Silva da Costa
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
